全文获取类型
收费全文 | 3821篇 |
免费 | 413篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 117篇 |
妇产科学 | 45篇 |
基础医学 | 418篇 |
口腔科学 | 162篇 |
临床医学 | 484篇 |
内科学 | 677篇 |
皮肤病学 | 21篇 |
神经病学 | 257篇 |
特种医学 | 91篇 |
外科学 | 679篇 |
综合类 | 78篇 |
一般理论 | 2篇 |
预防医学 | 444篇 |
眼科学 | 94篇 |
药学 | 273篇 |
中国医学 | 5篇 |
肿瘤学 | 339篇 |
出版年
2022年 | 31篇 |
2021年 | 62篇 |
2020年 | 44篇 |
2019年 | 61篇 |
2018年 | 72篇 |
2017年 | 55篇 |
2016年 | 66篇 |
2015年 | 92篇 |
2014年 | 113篇 |
2013年 | 133篇 |
2012年 | 194篇 |
2011年 | 205篇 |
2010年 | 101篇 |
2009年 | 105篇 |
2008年 | 170篇 |
2007年 | 169篇 |
2006年 | 200篇 |
2005年 | 211篇 |
2004年 | 213篇 |
2003年 | 188篇 |
2002年 | 147篇 |
2001年 | 106篇 |
2000年 | 93篇 |
1999年 | 81篇 |
1998年 | 43篇 |
1997年 | 31篇 |
1996年 | 39篇 |
1994年 | 29篇 |
1993年 | 27篇 |
1992年 | 71篇 |
1991年 | 67篇 |
1990年 | 59篇 |
1989年 | 63篇 |
1988年 | 59篇 |
1987年 | 56篇 |
1986年 | 55篇 |
1985年 | 55篇 |
1984年 | 38篇 |
1983年 | 47篇 |
1982年 | 29篇 |
1981年 | 25篇 |
1979年 | 38篇 |
1978年 | 38篇 |
1977年 | 30篇 |
1976年 | 39篇 |
1974年 | 47篇 |
1973年 | 39篇 |
1972年 | 35篇 |
1971年 | 30篇 |
1969年 | 24篇 |
排序方式: 共有4244条查询结果,搜索用时 15 毫秒
1.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献2.
3.
4.
Objective: Considering the growing use of cellular phones and the fast appearance of new phone models, the electromagnetic interference of currently popular cellular phones on electronic medical equipment was tested. Methods: Three Personal Communication System cellular phones were put at different distances from multiple electronic medical devices, the interference effect was observed and the electromagnetic field strength measured with a spectrum analyser. Results: Only two small pieces of equipment, the CO2 airway adapter and the haemoglucostix meter were affected and then only when the phone was in very close proximity. Conclusion: Compared to the results of our study in 1997 testing Global System for Mobile Communication phones, the Personal Communication System phones generated less electromagnetic interference. However a much larger scaled study and an accurate international electromagnetic interference standard are recommended before any change in the current restrictive hospital policy on mobile phone usage could be recommended. 相似文献
5.
6.
Wing‐Hong Li Moon‐Tong Cheung Candace N.S. Ho Ting‐Pong Fung Kai‐Ming Ko Kelvin K.W. Yau 《Surgical Practice》2007,11(4):138-143
Aim: To examine the survival benefit of liver and lung resection for colorectal metastasis and the potential prognostic factors that affect patient survival. Methods: All patients who had resection of lung or liver metastasis for colorectal metastasis in Queen Elizabeth Hospital, Hong Kong from 1995 to 2004 were retrospectively reviewed. The overall and disease‐free survival was analysed, in particularly between liver and lung metastasis. All factors that may have affected the survival were entered into Cox's proportional hazards regression model to identify significant variables associated with survival. Results: At 5 years, the overall survival of patients who had resection of lung and liver metastasis was 44% and 38%, respectively; the disease‐free survival was 26% and 24%, respectively. Overall and disease‐free survival of patients with resection of lung metastasis was comparable to those with resection of liver metastasis. The differentiations of primary tumour and time to metastasis were shown to be significant prognostic factors influencing overall survival. Those patients with systemic chemotherapy after resection of colorectal metastasis demonstrated a significantly higher probability of overall survival. Conclusion: Resection of lung and liver metastases from colorectal origin was safe and both procedures improved survival. The use of chemotherapy after resection of metastasis significantly improved the overall survival. 相似文献
7.
Manifestations and treatment of 793 cases of decompression sickness in a compressed air tunneling project in Hong Kong 总被引:1,自引:0,他引:1
In the largest compressed air tunneling contract for the construction of the Island Line of the Mass Transit Railway system in Hong Kong, 154,390 man-decompressions occurred, of which 142,140 were after exposures to 1 bar (1.97 ATA, 14.7 psig) or above. The maximum working pressure (MWP) was 3.30 bar (4.26 ATA, 47.9 psig). There were 792 cases of type I and 1 case of type II decompression sickness. The manifestations of the cases were generally similar to those reported elsewhere. Oxygen treatment was given to 9 cases and all were successfully treated with no recurrence of symptoms. Minimum effective pressure treatment on 783 type I cases was successful, with 9.6% requiring two or more recompressions. The pressure required to relieve symptoms was more closely related to the interval between completion of decompression after work and commencement of treatment than to the delay between onset of symptoms and treatment. For every 1-h interval or every 1-h delay, an additional pressure of 0.04 bar (0.04 ATA, 0.58 psi) above MWP was required for pain relief. Step-wise multiple regression analysis showed that the four predictors for pressure of relief and the highest pressure used in recompression, respectively, were, in order of descending importance, maximum working pressure, interval before treatment, bends sequence (the nth attack of bends experienced in the present contract, i.e., the sum of previous attacks and the present attack), and duration of exposure. 相似文献
8.
9.
Gilbert H. L. Tang Paul W. M. Fedak Terrence M. Yau Richard D. Weisel Alex Kulik Donald A. G. Mickle Ren-Ke Li 《European journal of cardio-thoracic surgery》2003,23(6):907-916
Current therapies for congestive heart failure are limited in efficacy or in applicability. Cardiac cell transplantation offers a novel therapeutic approach to improve heart function. Although significant progress has been made over the past decade in the development of cell transplantation, only recently have investigators studied the changes in ventricular function following cell transplantation. This review article describes the latest research developments, evaluates recent studies of ventricular function after cell transplantation, and discusses the future directions of cell transplantation as a new therapy to ‘repair broken hearts’. 相似文献
10.
D R Luke J E Beck K Vadiei M Yousefpour C F LeMaistre J C Yau 《Journal of clinical pharmacology》1990,30(2):163-169
The metabolic effects of intravenous cyclosporine on lipids and lipoproteins were studied in 29 allogeneic bone marrow recipients compared with 13 autologous bone marrow patients not requiring cyclosporine therapy. Patients were monitored continuously from 5 days prior to 27 days following transplantation; cyclosporine treatment was initiated 4 days before transplantation. Fasting lipid and lipoprotein levels were measured in serial blood samples throughout the study period. Nutritional supplementation, conditioning regimens and concomitant medications were not significantly different between groups. Furthermore, no significant differences in age, weight, lipid, or lipoprotein levels were found at baseline between the patient groups. Cholesterol, triglyceride, low-density lipoprotein cholesterol, and very low-density lipoprotein cholesterol levels remained unchanged in autologous patients. As compared with baseline values, plasma total cholesterol increased by an average of 26 percent in allogeneic transplantation patients receiving cyclosporine. Similarly, the ratio of low-density lipoprotein to high-density lipoprotein cholesterol was fourfold greater in those patients treated with cyclosporine compared to the autologous group. We conclude that cyclosporine appears to elevate cholesterol levels. Neither acute graft vs host disease nor changes in hepatic function could explain the differences in plasma cholesterol levels between groups. 相似文献